Zevra Therapeutics, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Zevra Therapeutics, Inc. (ZVRA) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $1.79 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-05
- Zevra Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $2.32M.
- Zevra Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$529.00K.
- Zevra Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $412.00K, a 94.11% decline year-over-year.
- Zevra Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$4.73M.
- Zevra Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$15.59M.
- Zevra Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$3.60M, a 132.33% decline from fiscal 2023.
- Zevra Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $11.13M, a 255.48% increase from fiscal 2022.
- Zevra Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $3.13M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.79M 10-Q · filed 2026-08-05 | $2.20M derived: sum of 3 quarters · filed 2026-08-05 | -$2.53M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | -$529.00K 10-Q · filed 2026-05-06 | -$117.00K derived: sum of 2 quarters · filed 2026-05-06 | -$4.85M derived: sum of 3 quarters · filed 2026-05-06 | -$8.85M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $412.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$4.32M derived: sum of 2 quarters · filed 2026-03-09 | -$8.32M derived: sum of 3 quarters · filed 2026-08-05 | -$15.59M 10-K · filed 2026-03-09 | |||
| 2025-09-30 | -$4.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$8.73M derived: sum of 2 quarters · filed 2026-08-05 | -$16.00M 10-Q · filed 2025-11-05 | -$9.01M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | -$4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$11.27M 10-Q · filed 2026-08-05 | -$4.28M derived: sum of 3 quarters · filed 2026-08-05 | -$6.26M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | -$7.26M 10-Q · filed 2026-05-06 | -$273.00K derived: sum of 2 quarters · filed 2026-05-06 | -$2.26M derived: sum of 3 quarters · filed 2026-05-06 | -$3.56M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $6.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $5.00M derived: sum of 2 quarters · filed 2026-03-09 | $3.71M derived: sum of 3 quarters · filed 2026-03-09 | -$3.60M 10-K · filed 2026-03-09 | |||
| 2024-09-30 | -$1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.28M derived: sum of 2 quarters · filed 2025-11-05 | -$10.59M 10-Q · filed 2025-11-05 | -$4.86M derived: sum of 4 quarters · filed 2025-11-05 | |||
| 2024-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$8.60M 10-Q · filed 2025-08-12 | -$2.87M derived: sum of 3 quarters · filed 2025-08-12 | -$419.00K derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | -$7.31M 10-Q · filed 2025-05-13 | -$1.58M derived: sum of 2 quarters · filed 2025-05-13 | $877.00K derived: sum of 3 quarters · filed 2025-05-13 | -$12.00K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $8.18M derived: sum of 2 quarters · filed 2025-03-12 | $7.29M derived: sum of 3 quarters · filed 2025-03-12 | $11.13M 10-K · filed 2025-03-12 | |||
| 2023-09-30 | $2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.56M derived: sum of 2 quarters · filed 2024-11-13 | $5.40M 10-Q · filed 2024-11-13 | $5.79M 10-Q · filed 2023-11-07 | $7.27M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | -$889.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $2.95M 10-Q · filed 2024-08-14 | $3.34M 10-Q · filed 2023-08-14 | $4.82M derived: sum of 3 quarters · filed 2024-08-14 | $5.45M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $3.84M 10-Q · filed 2024-05-09 | $3.93M 10-Q · filed 2023-05-15 | $5.71M derived: sum of 2 quarters · filed 2024-05-09 | $6.34M derived: sum of 3 quarters · filed 2024-05-09 | $7.45M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $2.50M derived: sum of 2 quarters · filed 2024-04-01 | $3.62M derived: sum of 3 quarters · filed 2024-04-01 | $3.13M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $632.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.75M derived: sum of 2 quarters · filed 2023-11-07 | $1.26M 10-Q · filed 2023-11-07 | $2.04M derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2022-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $630.00K 10-Q · filed 2023-08-14 | $1.41M derived: sum of 3 quarters · filed 2023-08-14 | $1.22M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | -$486.00K 10-Q · filed 2023-05-15 | -$418.00K 10-Q · filed 2022-05-12 | $292.00K derived: sum of 2 quarters · filed 2023-05-15 | $103.00K derived: sum of 3 quarters · filed 2023-05-15 | $221.00K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $778.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $589.00K derived: sum of 2 quarters · filed 2023-03-07 | $707.00K derived: sum of 3 quarters · filed 2023-03-07 | -$1.11M 10-K · filed 2023-03-07 | |||
| 2021-09-30 | -$189.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$71.00K derived: sum of 2 quarters · filed 2022-11-10 | -$1.89M 10-Q · filed 2022-11-10 | $339.00K derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $118.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$1.70M 10-Q · filed 2022-08-12 | $528.00K derived: sum of 3 quarters · filed 2022-08-12 | $174.00K derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | -$1.82M 10-Q · filed 2022-05-12 | $410.00K derived: sum of 2 quarters · filed 2022-05-12 | $56.00K derived: sum of 3 quarters · filed 2022-05-12 | -$1.48M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.88M derived: sum of 2 quarters · filed 2022-03-31 | $345.00K derived: sum of 3 quarters · filed 2022-03-31 | $931.00K 10-K · filed 2022-03-31 | |||
| 2020-09-30 | -$354.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$1.89M derived: sum of 2 quarters · filed 2021-11-10 | -$1.30M 10-Q · filed 2021-11-10 | $985.00K derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | -$1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$945.00K 10-Q · filed 2021-08-13 | $1.34M derived: sum of 3 quarters · filed 2021-08-13 | -$2.33M derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $586.00K 10-Q · filed 2021-05-14 | $2.87M derived: sum of 2 quarters · filed 2021-05-14 | -$804.00K derived: sum of 3 quarters · filed 2021-05-14 | -$2.18M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$1.39M derived: sum of 2 quarters · filed 2021-03-12 | -$2.76M derived: sum of 3 quarters · filed 2021-03-12 | -$3.79M 10-K · filed 2021-03-12 | |||
| 2019-09-30 | -$3.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | -$5.05M derived: sum of 2 quarters · filed 2020-10-30 | -$6.07M 10-Q · filed 2020-10-30 | -$13.49M derived: sum of 4 quarters · filed 2020-10-30 | |||
| 2019-06-30 | -$1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$2.40M 10-Q · filed 2020-08-12 | -$9.81M derived: sum of 3 quarters · filed 2020-08-12 | -$8.10M derived: sum of 4 quarters · filed 2020-08-12 | |||
| 2019-03-31 | -$1.03M 10-Q · filed 2020-05-13 | -$8.44M derived: sum of 2 quarters · filed 2020-05-13 | -$6.72M derived: sum of 3 quarters · filed 2020-05-13 | -$3.93M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | -$7.42M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$5.70M derived: sum of 2 quarters · filed 2020-02-28 | -$2.90M derived: sum of 3 quarters · filed 2020-02-28 | -$1.64M 10-K · filed 2020-02-28 | |||
| 2018-09-30 | $1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $4.51M derived: sum of 2 quarters · filed 2019-11-14 | $5.78M 10-Q · filed 2019-11-14 | $6.05M derived: sum of 4 quarters · filed 2019-11-14 | |||
| 2018-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $4.06M 10-Q · filed 2019-08-13 | $4.34M derived: sum of 3 quarters · filed 2019-08-13 | $5.58M derived: sum of 4 quarters · filed 2019-08-13 | |||
| 2018-03-31 | $1.27M 10-Q · filed 2019-05-14 | $1.54M derived: sum of 2 quarters · filed 2019-05-14 | $2.79M derived: sum of 3 quarters · filed 2019-05-14 | $3.33M derived: sum of 4 quarters · filed 2019-05-14 | |||
| 2017-12-31 | $274.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $1.52M derived: sum of 2 quarters · filed 2019-03-01 | $2.07M derived: sum of 3 quarters · filed 2019-03-01 | -$801.00K 10-K · filed 2019-03-01 | |||
| 2017-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.79M derived: sum of 2 quarters · filed 2018-11-09 | -$1.07M 10-Q · filed 2018-11-09 | -$341.00K derived: sum of 4 quarters · filed 2018-11-09 | |||
| 2017-06-30 | $549.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$2.32M 10-Q · filed 2018-08-10 | -$1.58M derived: sum of 3 quarters · filed 2018-08-10 | -$507.00K derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2017-03-31 | -$2.87M 10-Q · filed 2018-05-11 | -$2.13M derived: sum of 2 quarters · filed 2018-05-11 | -$1.06M derived: sum of 3 quarters · filed 2018-05-11 | -$1.07M derived: sum of 4 quarters · filed 2018-05-11 | |||
| 2016-12-31 | $734.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $1.81M derived: sum of 2 quarters · filed 2018-03-30 | $1.80M derived: sum of 3 quarters · filed 2018-03-30 | $1.12M 10-K · filed 2018-03-30 | |||
| 2016-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.06M derived: sum of 2 quarters · filed 2017-11-09 | $384.00K 10-Q · filed 2017-11-09 | $673.00K 10-Q · filed 2016-11-10 | $946.00K derived: sum of 4 quarters · filed 2018-03-30 | ||
| 2016-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$693.00K 10-Q · filed 2017-08-10 | -$131.00K derived: sum of 3 quarters · filed 2018-03-30 | $2.80M derived: sum of 4 quarters · filed 2018-03-30 | |||
| 2016-03-31 | -$679.00K 10-Q · filed 2017-05-22 | -$117.00K derived: sum of 2 quarters · filed 2018-03-30 | $2.81M derived: sum of 3 quarters · filed 2018-03-30 | $1.61M derived: sum of 4 quarters · filed 2018-03-30 | |||
| 2015-12-31 | $562.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $3.49M derived: sum of 2 quarters · filed 2018-03-30 | $2.29M derived: sum of 3 quarters · filed 2018-03-30 | $1.31M 10-K · filed 2018-03-30 | |||
| 2015-09-30 | $2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.73M derived: sum of 2 quarters · filed 2016-11-10 | $753.00K 10-Q · filed 2016-11-10 | -$1.78M 10-Q · filed 2015-11-13 | $370.00K derived: sum of 4 quarters · filed 2017-03-10 | ||
| 2015-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$2.17M 10-Q · filed 2016-08-11 | -$2.56M derived: sum of 3 quarters · filed 2017-03-10 | -$1.83M derived: sum of 4 quarters · filed 2017-03-10 | |||
| 2015-03-31 | -$977.00K 10-Q · filed 2016-05-13 | -$1.36M derived: sum of 2 quarters · filed 2017-03-10 | -$633.00K derived: sum of 3 quarters · filed 2017-03-10 | -$632.00K derived: sum of 4 quarters · filed 2017-03-10 | |||
| 2014-12-31 | -$383.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $344.00K derived: sum of 2 quarters · filed 2017-03-10 | $345.00K derived: sum of 3 quarters · filed 2017-03-10 | $933.00K 10-K · filed 2017-03-10 | |||
| 2014-09-30 | $727.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $728.00K derived: sum of 2 quarters · filed 2015-11-13 | $1.32M 10-Q · filed 2015-11-13 | ||||
| 2014-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $589.00K 10-Q · filed 2015-08-14 | |||||
| 2014-03-31 | $588.00K 10-Q · filed 2015-05-29 | ||||||
| 2013-12-31 | $126.00K 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |